Overview

A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/Cobicistat

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This study aims to provide the evidence that 150mg of cobicistat will have the same effect on the pharmacokinetics of daclatasvir 30mg QD as 100mg of ritonavir, when given together with atazanavir 300mg.
Phase:
Phase 1
Details
Lead Sponsor:
Radboud University
Treatments:
Anti-Retroviral Agents
Atazanavir Sulfate
Cobicistat
Ritonavir